1.
Sotiriou E, Tsentemeidou A, Sideris N, et al. Apremilast survival and reasons for discontinuation in psoriasis: five-year experience from a Greek tertiary care centre. Dermatol Pract Concept. 2022;12(2):e2022076. doi:10.5826/dpc.1202a76